Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
Clinical trial NCT00254202 · COMPLETED
Trial details
- NCT number
- NCT00254202
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-18
- Primary completion
- 2006-09-26
- Enrollment
- 593
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.